BioInsights - Challenges in viral vector raw materials procurement & management
Raw Materials 2019

Challenges in viral vector raw materials procurement & management

Cell & Gene Therapy Insights 2019; 5(10), 1305-1310.

10.18609/cgti.2019.136

Published: 1 November 2019
Interview
Kathleen Szczur

Kathleen Szczur

Senior Specialist in the Vector Production Group at Cincinnati Children’s Hospital Medical Center (CCHMC), has over 21 years of experience in both basic science research and Phase 1/2 GMP manufacturing. She began her career in production of GMP clinical supplies and analytical chemistry at a small firm working with biodegradable polymers to develop long-acting delivery systems of various molecules. She continued her career researching immune function at Shriners Burns Hospital, Cincinnati, OH, in the lab of Cora K Ogle, PhD and hematopoiesis with the Experimental Hematology and Cancer Biology group at CCHMC in the lab of David A Williams, MD and Marie-Dominique Filippi, PhD. Her current position involves manufacturing of viral vectors for both academic and commercial customers to advance the field of gene therapy.